There is no satisfactory biomarker yet available for predicting the likelihood of premalignant changes or carcinoma developing in Barrett's or columnar lined oesophagus. In this study we have evaluated the proliferation of squamous epithelium, columnar epithelium from columnar lined oesophagus and gastric columnar epithelium from 23 Barrett's patients using positive immunoreactivity with the mouse monoclonal antibody Ki67 (which recognises an antigen associated with proliferative cells) with a view to using this parameter as a biomarker. Squamous epithelium had significantly higher Ki67 immunostaining as compared with columnar epithelium from columnar lined oesophagus (when examining the tissue with greater than 15% cells staining positive for Ki67, Fisher's exact test p=0.004) but there was no difference found between the epithelium from the columnar lined oesophagus and gastric columnar epithelium. There was no correlation between histological inflammation and Ki67 immunoreactivity of Barrett's mucosa, and the Ki67 immunostaining of two patients with dysplasia was no different from the rest of the group. There was, however, a significant correlation between the Ki67 immunoreactivity of columnar epithelium from columnar lined oesophagus and columnar epithelium from the stomach (correlation coefficient=044, p=003) suggesting that epithelium from columnar lined oesophagus behaves in a similar fashion to gastric epithelium.
Cell renewal in intestinal epithelium is an orderly sequential process proceeding from proliferation of cells in the basal layer through maturation of the daughter cells to formation of the epithelial cells lining the intestinal mucosa. This pattern is altered in pathological states, which can be characterised by an increased intestinal cell turnover rate. ' For example, colonic epithelium in ulcerative colitis is characterised by an increase in the proportion of epithelial cells synthesising DNA," and upward expansion of the proliferative zone.'-'
Gastrooesophageal refluxate causes cell damage in the oesophageal mucosa and the consequent reparative response also results in just such proliferative alterations. In some patients with chronic gastrooesophageal reflux, metaplastic change in the oesophageal mucosa also occurs and squamous is replaced by columnar epithelium`resulting in 'Barrett's or columnar lined oesophagus'. This columnar epithelium has the potential for malignant change,67 but although attempts have been made to detect such transformation at a premalignant stage, histological dysplasia remains the only reliable index to date.' It is of interest, however, that in Barrett's epithelium, dysplasia is sometimes associated with aneuploidy, and occasionally aneuploidy is seen in the absence of dysplasia. It has therefore been suggested that ploidy status may be a marker for malignant changes which precedes the development of histological abnormalities. 9 The proliferative activity of cells has been evaluated in several pathological conditions,">" and thymidine labelling index," bromodeoxyuridine in situ labelling,' -6 DNA flow cytometry,'7 and Ki67 immunohistochemistry have been used to quantify the mitotic index in malignant" "'`and benign disease. 22-2 This approach has not, however, been evaluated in columnar lined oesophagus.
Ki67 is a mouse monoclonal antibody that recognises a nuclear antigen which is expressed in all phases of the cell cycle except GO (the quiescent phase), and is therefore associated with cell proliferation. " common feature of columnar lined oesophagus and not sufficiently discriminatory to detect a subgroup of patients at high risk of malignant change.33 Similarly, differences in ornithine decarboxylase activity in non-dysplastic and dysplastic epithelium of columnar lined oesophagus has not been observed.34 To date, several methods for the assessment of cellular proliferation have been used in an attempt to quantify various stages of the cell cycle and to relate these to the biological behaviour of the cell.35 In the present study, the Ki67 mouse monoclonal antibody has been used to determine the level of proliferation of squamous, columnar and gastric epithelium from patients with Barrett's oesophagus. The squamous epithelium in these patients had a higher level of proliferation than the Barrett's epithelium, a finding in contrast with that of Herbst and his colleagues30 who showed by the indirect method of in vitro thymidine labelling that cell turnover was much slower in the squamous epithelium as compared with Barrett's epithelium of patients with columnar lined oesophagus.
No previous attempts have been made to compare the proliferation of Barrett's epithelium and gastric epithelium obtained from the same patients. In this study no difference between the proliferation of Barrett's epithelium and gastric epithelium was found. One possible explanation of higher Ki67 immunostaining in squamous mucosa in these patients may be that this epithelium bears the brunt of gastrooesophageal reflux whereas Barrett's epithelium is more akin to gastric epithelium and can withstand the harmful effect of gastric juice. The Ki67 staining of normal squamous epithelium has not been studied, however, and although there is evidence that in ulcerative colitis subjects there is abnormal cell renewal' and higher proliferation in inflamed mucosa, the inflamed Barrett's mucosa in this study did not exhibit enhanced levels of Ki67 immunostaining.
No correlation between the Ki67 immunostaining of the squamous and columnar epithelium from columnar lined oesophagus subjects was found, but a significant positive correlation was found between the Barrett's epithelium and gastric epithelium. This is in concordance with the findings of Herbst In this study it has been shown that squamous epithelium has a higher proliferative index than Barrett's epithelium in columnar lined oesophagus patients and that oesophageal columnar epithelium behaves in similar fashion to gastric columnar epithelium. Owing to small numbers of dysplastic or aneuploid biopsies, however, it has not been possible in this study to show that Ki67 immunostaining is related to these histological or cytometric features. In addition any value that it may have as a biomarker or in defining a subgroup of patients who may be prone to future development of dysplasia or adenocarcinoma in their columnar lined oesophagus can only be investigated by prolonged follow up. 
